Who Holds Aligos Therapeutics, Inc. (ALGS)? 31 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 31 holders, $13 million in total.
Largest holders
The 31 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Deep Track Capital, LP | 444,110 | $3 million | +0% | 13F |
| Alyeska Investment Group, L.P. | 412,000 | $2 million | +0% | 13F |
| Sio Capital Management, LLC | 327,237 | $2 million | +0% | 13F |
| MARSHALL WACE, LLP | 246,579 | $1 million | -8% | 13F |
| Woodline Partners LP | 177,362 | $1 million | +0% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 175,543 | $1 million | -2% | 13F |
| BAKER BROS. ADVISORS LP | 83,055 | $479,227 | +0% | 13F |
| HHLR ADVISORS, LTD. | 76,247 | $439,945 | +0% | 13F |
| D. E. Shaw & Co., Inc. | 66,463 | $383,491 | +505% | 13F |
| UBS Group AG | 59,986 | $346,119 | +62% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 47,173 | $272,319 | -6% | 13F |
| JANE STREET GROUP, LLC | 32,402 | $186,959 | New | 13F |
| BlackRock, Inc. | 30,292 | $174,785 | +132% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 28,612 | $165,091 | +1% | 13F |
| DIMENSIONAL FUND ADVISORS LP | 21,044 | $121,424 | New | 13F |
| Verition Fund Management LLC | 18,887 | $108,978 | +0% | 13F |
| Trexquant Investment LP | 12,339 | $71,196 | New | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 10,800 | $62,316 | -89% | 13F |
| Rockefeller Capital Management L.P. | 10,000 | $57,700 | +0% | 13F |
| Federation des caisses Desjardins du Quebec | 4,650 | $26,831 | +389% | 13F |
| Golden State Wealth Management, LLC | 2,674 | $15,429 | +0% | 13F |
| ROYAL BANK OF CANADA | 2,125 | $12,000 | +0% | 13F |
| CITIGROUP INC | 1,808 | $10,432 | New | 13F |
| Tower Research Capital LLC (TRC) | 359 | $2,071 | +452% | 13F |
| JPMORGAN CHASE & CO | 344 | $1,868 | -49% | 13F |
| MORGAN STANLEY | 204 | $1,177 | -6% | 13F |
| SBI Securities Co., Ltd. | 126 | $727 | +385% | 13F |
| WELLS FARGO & COMPANY/MN | 100 | $577 | -86% | 13F |
| FMR LLC | 10 | $58 | New | 13F |
| ELEVATION WEALTH PARTNERS, LLC | 4 | $24 | +0% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 3 | $17 | +0% | 13F |
Questions and answers
- How many institutions hold Aligos Therapeutics, Inc.?
- 31 managers reported Aligos Therapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 34 the quarter before.
- Who is the largest institutional holder of Aligos Therapeutics, Inc.?
- Deep Track Capital, LP, with 444,110 shares worth $3 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Aligos Therapeutics, Inc. in Q2 2026?
- 5 managers reported a new position and 8 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Aligos Therapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/aligos-therapeutics, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.